Ajanta Pharma, Granules India, and Sun Pharmaceutical also traded with losses, ranging between 2% and 4%. Uncertainty surrounding the scale of US tariffs, the possibility of retaliatory measures ...

The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...

It is a pleasure for Amlan International to collaborate with Alembic Pharmaceuticals India that has a strong legacy with a global footprint. This agreement will lay the framework for cultivating ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.

The NPPA has taken enforcement action against multiple pharmaceutical firms for non-compliance. M/s ANG Lifescience India Limited and M/s Ridley Life Science Private Limited have been blacklisted ...

Below are five principal takeaways of what we heard about U.S.-India relations, how India sees its role in the Indo-Pacific, and how it plans to navigate a second Trump administration. India views ...

About VensureHR VensureHR is part of Vensure Employer Solutions, the largest privately held organization in the HR technology and service sector, providing a comprehensive portfolio of solutions ...

The Uttar Pradesh government, led by CM Yogi Adityanath, has issued strict directives to shut down illegal slaughterhouses and ban meat sales within a 500-meter radius of religious sites.

Involves transaction of at least 0.5% of the listed shares of a company. What was Nippon India NIFTY Pharma ETF Growth Plan share price previously? Nippon India NIFTY Pharma ETF Growth Plan share ...

NEW DELHI, March 25 (Reuters) - India is open to cutting tariffs on ... The second official said the $11 billion worth of pharmaceutical and automotive exports may see the most disruptive impact ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...